KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2021 | |
|---|---|---|---|---|
| Revenue | $60 | $28 | $8 | $0 |
| % Growth | 115.1% | 264.5% | – | – |
| Cost of Goods Sold | $36 | $27 | $18 | $0 |
| Gross Profit | $24 | $0 | -$11 | $0 |
| % Margin | 40.5% | 1.3% | -139.6% | – |
| R&D Expenses | $16 | $15 | $16 | $19 |
| G&A Expenses | $0 | $29 | $19 | $0 |
| SG&A Expenses | $115 | $70 | $54 | $14 |
| Sales & Mktg Exp. | $0 | $41 | $35 | $14 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $131 | $85 | $70 | $33 |
| Operating Income | -$106 | -$85 | -$80 | -$33 |
| % Margin | -177.8% | -305.8% | -1,054% | – |
| Other Income/Exp. Net | -$7 | -$9 | -$4 | -$1 |
| Pre-Tax Income | -$114 | -$94 | -$84 | -$34 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$114 | -$94 | -$84 | -$34 |
| % Margin | -190.3% | -338.4% | -1,104% | – |
| EPS | -5.13 | -2.04 | -1.75 | -0.69 |
| % Growth | -151.5% | -16.6% | -153.6% | – |
| EPS Diluted | -5.13 | -2.04 | -1.75 | -0.69 |
| Weighted Avg Shares Out | 50 | 50 | 50 | 50 |
| Weighted Avg Shares Out Dil | 50 | 50 | 50 | 50 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $0 | $0 | $0 |
| Interest Expense | $8 | $6 | $6 | $1 |
| Depreciation & Amortization | $8 | $12 | $5 | $0 |
| EBITDA | -$98 | -$76 | -$74 | -$32 |
| % Margin | -163.8% | -274.3% | -966.4% | – |